SCIENTIFIC PRINCIPLES.
The foundational science of biotic systems.
Foundational Biotics
The science of bioticine focuses on quantifiable interactions between microbial entities and host physiology. We reject qualitative wellness claims in favor of measurable outputs like SCFA (Short-Chain Fatty Acid) concentrations and mucosal integrity biomarkers (Zonulin, Calprotectin). Studies (Meyer et al., 2022) demonstrate that targeted strain administration alters tight junction protein expression by up to 34%.
Metric Tolerances
| Marker | Baseline Range | Target Range |
|---|---|---|
| Fecal Butyrate | 10-15 mmol/L | > 20 mmol/L |
| Zonulin (Serum) | > 45 ng/mL | < 30 ng/mL |
Tool: SCFA Yield Estimator
Common Mistakes in Scientific Application
- Assuming all fiber ferments equally. Soluble vs insoluble ratios matter significantly when designing a prebiotic matrix.
- Measuring blood serum for localized gut metabolites, which provides a false reading of lumenal concentrations.
FAQ Section
How does Bioticine measure success scientifically?
Success is measured exclusively via validated biomarkers (e.g., reductions in calprotectin) rather than subjective patient reporting. Our clinical data outlines specific endpoints.
Are all strains scientifically proven?
No. Efficacy is entirely strain-specific. A probiotic formulation must be evaluated at the strain level, not just the genus or species.